Amoéba

Amoéba’s ambition is to become a major player in the treatment of bacterial risk in the fields of water, healthcare and plant protection. Our biological solution is an alternative to chemical products widely used today. Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada and in the United States, Amoéba is quoted on the compartment C of Euronext Paris. The Company is a member of the BPIfrance Excellence network and is eligible for the PEA-PME SME equity savings plan setup.

Follow

News10

• AMOEBA : Efficacy of biocontrol products to fight tomato late blight and powdery mildew in tomatoes

  Oct. 24, 2023

  # Science & Research #

• AMOEBA introduces its AXPERA brand for the biocontrol application

  Jun. 6, 2023

  # Biopesticide & Biocontrol #

• Amoéba announces its collaboration with Nissan Chemical Corporation for the biocontrol application

  Apr. 4, 2023

• Amoéba: a 2nd cereal trial campaign confirms the potential of its biocontrol product

  Aug. 30, 2021

  # Fungicides & Bactericides #

• Amoeba has filed the application for approval of its biocontrol solution in Europe

  Jun. 1, 2020

• With 8 research partnerships in biocontrol, Amoeba confirms a new development phase

  May. 1, 2020

  # Fungicides & Bactericides #

• Amoeba signs a material transfer agreement with Bayer for its biocontrol solutions

  Apr. 23, 2020

• Syngenta and Amoéba launch a targeted research phase in biocontrol products

  Apr. 17, 2020

  # Fungicides & Bactericides #

• Amoéba and Stähler partner to evaluate innovative crop biocontrol products

  Mar. 27, 2020

• New eco-friendly treatment stops rust on crops

  Jul. 5, 2019